Comparative study of cathepsin B-cleavable linkers for the optimal design of cathepsin B-specific doxorubicin prodrug nanoparticles for targeted cancer therapy
- Biomaterials, Volume 289, October 2022, 121806 | https://doi.org/10.1016/j.biomaterials.2022.121806